| 0.921 | 0.001 | 0.921 | Acetylcholine nicotinic antagonist | | |
| 0.919 | 0.001 | 0.919 | Neuronal nicotinic receptor antagonist | | |
| 0.82 | 0.002 | 0.82 | Nicotinic receptor alpha7 subunit antagonist | | |
| 0.815 | 0 | 0.815 | Cathepsin G inhibitor | | |
| 0.813 | 0.001 | 0.813 | Integrin alpha4beta1 antagonist | | |
| 0.812 | 0.004 | 0.812 | Antithrombotic | | |
| 0.724 | 0.004 | 0.724 | Integrin antagonist | | |
| 0.681 | 0.01 | 0.681 | Antibacterial | | |
| 0.648 | 0.004 | 0.648 | Acetylcholine antagonist | | |
| 0.642 | 0.004 | 0.642 | Diuretic | | |
| 0.636 | 0.002 | 0.636 | Growth hormone release inhibitor | | |
| 0.631 | 0.004 | 0.631 | Cholinergic antagonist | | |
| 0.618 | 0.01 | 0.618 | Interleukin antagonist | | |
| 0.583 | 0.002 | 0.583 | Erythropoietin receptor agonist | | |
| 0.573 | 0.009 | 0.573 | Calcium channel L-type activator | | |
| 0.557 | 0.003 | 0.557 | Somatostatin agonist | | |
| 0.546 | 0.003 | 0.546 | VLA-4 antagonist | | |
| 0.516 | 0.005 | 0.516 | Nav1.2 sodium channel blocker | | |
| 0.495 | 0.002 | 0.495 | Somatostatin 2 antagonist | | |
| 0.48 | 0.003 | 0.48 | Nicotinic receptor alpha3 subunit antagonist | | |
| 0.474 | 0.011 | 0.474 | Interleukin 2 agonist | | |
| 0.463 | 0.002 | 0.463 | Somatostatin 5 agonist | | |
| 0.457 | 0.001 | 0.457 | Somatostatin 1 agonist | | |
| 0.45 | 0.002 | 0.45 | Factor XII inhibitor | | |
| 0.448 | 0.001 | 0.448 | Nav1.4 sodium channel blocker | | |
| 0.458 | 0.014 | 0.458 | Insulysin inhibitor | | |
| 0.468 | 0.033 | 0.468 | Immunostimulant | | |
| 0.426 | 0.005 | 0.426 | Cell adhesion inhibitor | | |
| 0.416 | 0.002 | 0.416 | Somatostatin 5 antagonist | | |
| 0.415 | 0.003 | 0.415 | Integrin alpha5beta1 antagonist | | |
| 0.412 | 0.001 | 0.412 | Somatostatin 4 antagonist | | |
| 0.412 | 0.003 | 0.412 | Integrin alpha4 antagonist | | |
| 0.41 | 0.002 | 0.41 | Nicotinic receptor beta4 subunit antagonist | | |
| 0.405 | 0.007 | 0.405 | Hemostatic | | |
| 0.398 | 0.003 | 0.398 | Integrin beta5 antagonist | | |
| 0.408 | 0.025 | 0.408 | Platelet antagonist | | |
| 0.377 | 0.001 | 0.377 | Somatostatin 1 antagonist | | |
| 0.352 | 0.004 | 0.352 | Nav1.5 sodium channel blocker | | |
| 0.346 | 0.004 | 0.346 | Melanocortin 3 antagonist | | |
| 0.338 | 0.004 | 0.338 | CXC chemokine 4 receptor antagonist | | |
| 0.336 | 0.005 | 0.336 | Melanocortin antagonist | | |
| 0.327 | 0.002 | 0.327 | Antidiuretic hormone agonist | | |
| 0.308 | 0.004 | 0.308 | Kallikrein inhibitor | | |
| 0.307 | 0.003 | 0.307 | Oxytocin antagonist | | |
| 0.299 | 0.004 | 0.299 | Antidiuretic hormone antagonist | | |
| 0.304 | 0.01 | 0.304 | Cell wall synthesis inhibitor | | |
| 0.368 | 0.077 | 0.368 | Immunosuppressant | | |
| 0.3 | 0.009 | 0.3 | Nav1.3 sodium channel blocker | | |
| 0.35 | 0.059 | 0.35 | Immunomodulator | | |
| 0.307 | 0.017 | 0.307 | Amylase inhibitor | | |
| 0.293 | 0.005 | 0.293 | Melanocortin 4 antagonist | | |
| 0.287 | 0.004 | 0.287 | Chymotrypsin inhibitor | | |
| 0.262 | 0.005 | 0.262 | Melanocortin 1 antagonist | | |
| 0.274 | 0.028 | 0.274 | Thrombolytic | | |
| 0.245 | 0.004 | 0.245 | Vasopressin 1 antagonist | | |
| 0.253 | 0.019 | 0.253 | Adenylate cyclase inhibitor | | |
| 0.266 | 0.035 | 0.266 | Anticoagulant | | |
| 0.232 | 0.004 | 0.232 | Melanocortin 1 agonist | | |
| 0.222 | 0.003 | 0.222 | Vasopressin 2 agonist | | |
| 0.219 | 0.006 | 0.219 | GP IIb/IIIa receptor antagonist | | |
| 0.214 | 0.002 | 0.214 | Somatostatin 3 antagonist | | |
| 0.221 | 0.014 | 0.221 | Nav1.6 sodium channel blocker | | |
| 0.214 | 0.009 | 0.214 | Opioid delta receptor antagonist | | |
| 0.208 | 0.012 | 0.208 | EphA2 antagonist | | |
| 0.216 | 0.021 | 0.216 | Proteasome inhibitor | | |
| 0.194 | 0.004 | 0.194 | Somatostatin 4 agonist | | |
| 0.196 | 0.006 | 0.196 | Plasmin inhibitor | | |
| 0.198 | 0.014 | 0.198 | Opioid antagonist | | |
| 0.192 | 0.011 | 0.192 | Hematopoietic | | |
| 0.187 | 0.011 | 0.187 | Opioid mu receptor antagonist | | |
| 0.174 | 0.005 | 0.174 | Glucagon-like peptide 1 agonist | | |
| 0.169 | 0.005 | 0.169 | Melanocortin agonist | | |
| 0.167 | 0.003 | 0.167 | Integrin beta7 antagonist | | |
| 0.147 | 0.004 | 0.147 | Vasopressin 1B antagonist | | |
| 0.143 | 0.004 | 0.143 | Vasopressin 2 antagonist | | |
| 0.142 | 0.003 | 0.142 | Growth hormone releasing factor antagonist | | |
| 0.138 | 0.005 | 0.138 | Vasopressin 1A antagonist | | |
| 0.139 | 0.005 | 0.139 | Melanocortin 5 agonist | | |
| 0.133 | 0.004 | 0.133 | Integrin beta3 antagonist | | |
| 0.134 | 0.006 | 0.134 | Melanocortin 5 antagonist | | |
| 0.126 | 0.003 | 0.126 | Integrin alpha4beta7 antagonist | | |
| 0.128 | 0.009 | 0.128 | Kallikrein 1 inhibitor | | |
| 0.15 | 0.033 | 0.15 | Nav1.1 sodium channel blocker | | |
| 0.115 | 0.002 | 0.115 | Urotensin II agonist | | |
| 0.116 | 0.004 | 0.116 | Kallikrein 7 inhibitor | | |
| 0.111 | 0.008 | 0.111 | Calcitonin receptor agonist | | |
| 0.104 | 0.005 | 0.104 | Melanocortin 3 agonist | | |
| 0.102 | 0.005 | 0.102 | Plasma kallikrein inhibitor | | |
| 0.098 | 0.004 | 0.098 | Somatostatin 2 agonist | | |
| 0.095 | 0.001 | 0.095 | Oxytocin agonist | | |
| 0.102 | 0.013 | 0.102 | Opioid mu receptor agonist | | |
| 0.104 | 0.015 | 0.104 | Trypsin inhibitor | | |
| 0.088 | 0.002 | 0.088 | Vasopressin 1A agonist | | |
| 0.102 | 0.016 | 0.102 | Urokinase inhibitor | | |
| 0.187 | 0.101 | 0.187 | Angiogenesis stimulant | | |
| 0.089 | 0.006 | 0.089 | Melanocortin 4 agonist | | |
| 0.23 | 0.15 | 0.23 | Sodium/bile acid cotransporter inhibitor | | |
| 0.107 | 0.028 | 0.107 | Analgesic, opioid | | |
| 0.082 | 0.002 | 0.082 | Vasopressin 1 agonist | | |
| 0.09 | 0.012 | 0.09 | Neurokinin 2 antagonist | | |
| 0.144 | 0.066 | 0.144 | Histone deacetylase SIRT1 inhibitor | | |
| 0.115 | 0.04 | 0.115 | Antineoplastic antibiotic | | |
| 0.101 | 0.034 | 0.101 | Cell adhesion molecule inhibitor | | |
| 0.135 | 0.072 | 0.135 | Bone formation stimulant | | |
| 0.063 | 0.002 | 0.063 | 1,3-Beta-glucan synthase inhibitor | | |
| 0.161 | 0.1 | 0.161 | P-glycoprotein inhibitor | | |
| 0.133 | 0.076 | 0.133 | Neurotrophic factor | | |
| 0.061 | 0.005 | 0.061 | Vitronectin receptor antagonist | | |
| 0.058 | 0.004 | 0.058 | Growth factor receptor-bound protein 2 antagonist | | |
| 0.062 | 0.009 | 0.062 | Endothelin receptor antagonist | | |
| 0.096 | 0.045 | 0.096 | Interleukin 5 antagonist | | |
| 0.072 | 0.022 | 0.072 | Opioid agonist | | |
| 0.107 | 0.058 | 0.107 | Ephrin antagonist | | |
| 0.052 | 0.003 | 0.052 | Somatostatin 3 agonist | | |
| 0.066 | 0.022 | 0.066 | Neurotensin receptor antagonist | | |
| 0.123 | 0.081 | 0.123 | Interleukin 4 antagonist | | |
| 0.175 | 0.137 | 0.175 | Peptidyltransferase inhibitor | | |
| 0.056 | 0.02 | 0.056 | Leukocyte elastase inhibitor | | |
| 0.049 | 0.014 | 0.049 | Opioid delta receptor agonist | | |
| 0.044 | 0.009 | 0.044 | Cyclophilin A inhibitor | | |
| 0.039 | 0.007 | 0.039 | Endothelin B receptor antagonist | | |
| 0.039 | 0.008 | 0.039 | Motilin receptor antagonist | | |
| 0.074 | 0.044 | 0.074 | CXC chemokine receptor antagonist | | |
| 0.056 | 0.028 | 0.056 | Neurokinin antagonist | | |
| 0.042 | 0.016 | 0.042 | Histone deacetylase class IV inhibitor | | |
| 0.042 | 0.016 | 0.042 | Histone deacetylase 11 inhibitor | | |
| 0.041 | 0.017 | 0.041 | Histone deacetylase 4 inhibitor | | |
| 0.08 | 0.058 | 0.08 | Opioid kappa receptor antagonist | | |
| 0.14 | 0.118 | 0.14 | Platelet adhesion inhibitor | | |
| 0.039 | 0.018 | 0.039 | Trypsin I inhibitor | | |
| 0.029 | 0.01 | 0.029 | Endothelin A receptor antagonist | | |
| 0.028 | 0.009 | 0.028 | Melatonin 3 antagonist | | |
| 0.026 | 0.01 | 0.026 | Integrin alphaVbeta3 antagonist | | |
| 0.032 | 0.019 | 0.032 | Histone deacetylase 10 inhibitor | | |
| 0.055 | 0.043 | 0.055 | Aminopeptidase microsomal inhibitor | | |
| 0.015 | 0.005 | 0.015 | Immunosuppressant Cyclosporine-like | | |
| 0.038 | 0.031 | 0.038 | Glucagon-like peptide 1 receptor antagonist | | |
| 0.015 | 0.011 | 0.015 | CXC chemokine 4 receptor agonist | | |
| 0.02 | 0.016 | 0.02 | Baculoviral IAP repeat-containing protein 3 inhibitor | | |
| 0.105 | 0.104 | 0.105 | Sodium channel (voltage-gated) blocker | | |
| 0.061 | 0.06 | 0.061 | Elastase 1 inhibitor | | |